Medicines Discovery Catapult
@MedDiscCat
Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery.
ID:3880382709
https://md.catapult.org.uk 06-10-2015 12:23:07
6,2K Tweets
18,7K Followers
1,0K Following
We have unrivalled pre-clinical imaging capabilities to accelerate your drug development.
We focus on non-invasive imaging modalities to study biodistribution, PK and PD, mechanism and efficacy of novel therapeutics.
Read more: hubs.li/Q02r15Cc0
#TranslationalImaging
If you missed our #MDCConnects #WebinarSeries you can now watch all of the inisghtful sessions on demand. ▶️
The webinars brought together experts in medicine discovery to share their knowledge and insights.
Click here to view all episodes: hubs.li/Q02rw9BJ0
🎯 Decision-making data.
Making the connections: Human iPSC-neurons connected through channels of a #microfluidics device.
#LifeSciences #Neuroscience #SMEs
Event: 23 April
Business Design Centre, London
Chief Strategy Officer Nicola Heron will be speaking at @lifearc #TranslationalScienceSummit event.
More information: hubs.li/Q02rw6Jl0
Another poster from this year's Alzheimer's Research UK Conference.
Use of #Microfluidics Technology to Model Pathogenic Protein Seeding in #Neurodegeneration in vitro.
🔗 hubs.li/Q02q-khX0
Did you see our posters from this year's Alzheimer's Research UK Conference?
#AdvancedMicroscopy Tools for #DrugDiscovery : Methods to Examine Cell Morphology and Function in CNS Disease Models.
🔗 hubs.li/Q02q-c5d0
🔋 Batteries of the brain: mitochondria in human iPSC-astrocytes.
🧠 Advances in human iPSC cell models, #biomarker research techniques, & a new understanding of the contribution of the immune system have led to a renewed interest in #neuroscience #DrugDiscovery .
🔬 Look at this amazing image from our #AdvancedMicroscopy team. Directly visualising biological events for a detailed understanding of disease phenotypes and drug mechanisms.
👉 Speak to us, and see if we can help.
🔗 hubs.li/Q02qTr180
#LifeSciences #DrugDiscovery
We can support your #DrugDiscovery
Our imaging platforms visualise the biodistribution of molecules in cells & tissues, track novel drug delivery & complex medicine modalities. Providing clear evidence of biomarker responses to novel drug candidates.
hubs.li/Q02qTpL20
Organ-on-Chips are microfluidic devices which mimic the structure and function of human organs.
#MDC alongside Professor Gautrot at Queen Mary University of London have collaborated to study responses in a controlled environment that can more accurately capture #HumanBiology .
hubs.li/Q02r1Sh80
Detecting #tumourDNA through #LiquidBiopsies marks the new frontier in #oncology , providing a wealth of critical data for #DrugDevelopment research.
Dr Andrzej Rutkowski, Lead Scientist at MDC, illuminates the value of this pioneering approach.
🔗 hubs.li/Q02qK-7P0
🎉 It's been an exciting 12 months!
🎯 Read how the therapeutic #TPPs we developed went on to shape the collaborative discovery programme focused on new treatments for #CysticFibrosis lung infections.
Read more: cfamr.org.uk/therapeutic-tpp
Medicines Discovery Catapult | @LifeArc1 | @CFTrust
At MDC, we have developed a comprehensive, cutting-edge evaluation platform to support the next generation of complex medicines, such as RNA therapeutics and antibody-drug conjugates.
MDC could support your #DrugDiscovery .
More: hubs.li/Q02qKZJH0
#LifeSciences
🔵Event: Innovation Landscape
📅 26 March
Tomorrow, Strategy Leader, Infectious Diseases Beverley Isherwood and Chief Scientific Officer Martin Main, will be taking part of the Society for Medicines Research #InnovationLandscape event.
More information can be found here: hubs.li/Q02qz2Yb0
Winners!
MDC received the award for ‘Non-Profit Life Science Innovation Enablers’ at last night’s One Nucleus award ceremony.
Read more: hubs.li/Q02qpW7q0
#OneNucleusAwards2024 #Winners #LifeSciences